Spectral properties and mechanisms that underlie autofluorescent accumulations in Batten disease

被引:17
作者
Seehafer, Sabrina S. [1 ]
Pearce, David A. [1 ,2 ,3 ]
机构
[1] Univ Rochester, Sch Med & Dent, Ctr Neural Dis & Dev, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA
关键词
Autofluorescent storage material; Neuronal Ceroid Lipofuscinosis; Microtubule assembly; Non-muscle myosin II; NEURONAL CEROID-LIPOFUSCINOSES; MITOCHONDRIAL ATP SYNTHASE; PROTEIN; INHIBITION; STORAGE; LIPOPIGMENT; SUBUNIT; BRAIN; FORMS;
D O I
10.1016/j.bbrc.2009.02.099
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuronal Ceroid Lipofuscinoses (NCLs) have an incidence of 1 in 12,500 live births. These devastating neurodegenerative lysosomal storage diseases are characterized by the lysosomal accumulation of autofluorescent storage material (AFSM) similar to that seen in aging cells. Using patient derived lymphoblasts from three genetically distinct NCLs we report that AFSM for each NCL has distinct spectral properties. Moreover, by using pharmacological inhibitors to disrupt various biochemical pathways in normal control lymphoblasts we have determined that disruptions in microtubule assembly and nonmuscle myosin II function results in accumulation of lysosomal AFSM. Interestingly, inhibition of autophagy did not result in AFSM. We conclude that cellular disturbances outside the lysosome in addition to compromised function of this organelle can result in accumulation of lysosomal AFSM in NCLs and possibly as a result of cellular aging. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:247 / 251
页数:5
相关论文
共 23 条
[1]   3-METHYLADENINE, AN INHIBITOR OF AUTOPHAGY, HAS MULTIPLE EFFECTS ON METABOLISM [J].
CARO, LHP ;
PLOMP, PJAM ;
WOLVETANG, EJ ;
KERKHOF, C ;
MEIJER, AJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (02) :325-329
[2]   INHIBITION OF ACTIN POLYMERIZATION BY LATRUNCULIN-A [J].
COUE, M ;
BRENNER, SL ;
SPECTOR, I ;
KORN, ED .
FEBS LETTERS, 1987, 213 (02) :316-318
[3]  
Drose S, 1997, J EXP BIOL, V200, P1
[4]   LIGHT AND ELECTRON-MICROSCOPIC APPEARANCE OF THE INNER-EAR IN JUVENILE CEROID LIPOFUSCINOSIS (CL) [J].
ELLEDER, M ;
VOLDRICH, L ;
ULEHLOVA, L ;
DIMITT, S ;
ARMSTRONG, D .
PATHOLOGY RESEARCH AND PRACTICE, 1988, 183 (03) :301-307
[5]   THE NEURONAL CEROID-LIPOFUSCINOSES [J].
GOEBEL, HH .
JOURNAL OF CHILD NEUROLOGY, 1995, 10 (06) :424-437
[6]   ALKALINIZING THE INTRALYSOSOMAL PH INHIBITS DE-GRANULATION OF HUMAN-NEUTROPHILS [J].
KLEMPNER, MS ;
STYRT, B .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (05) :1793-1800
[7]   HUMAN FORMS OF NEURONAL CEROID-LIPOFUSCINOSIS (BATTEN-DISEASE) - CONSENSUS ON DIAGNOSTIC-CRITERIA, HAMBURG 1992 [J].
KOHLSCHUTTER, A ;
GARDINER, RM ;
GOEBEL, HH .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (02) :241-244
[8]   EFFECTS OF NOCODAZOLE ON STRUCTURES OF CALF BRAIN TUBULIN [J].
LEE, JC ;
FIELD, DJ ;
LEE, LLY .
BIOCHEMISTRY, 1980, 19 (26) :6209-6215
[9]   Specificity of blebbistatin, an inhibitor of myosin II [J].
Limouze, J ;
Straight, AF ;
Mitchison, T ;
Sellers, JE .
JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY, 2004, 25 (4-5) :337-341
[10]   Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease) [J].
Palmer, DN ;
Jolly, RD ;
vanMil, HC ;
Tyynela, J ;
Westlake, VJ .
NEUROPEDIATRICS, 1997, 28 (01) :45-48